Australia's securities regulator said on Tuesday it would trial changes to speed up initial public offerings that are at a ...

Lenskart has converted to a public entity as it prepares for a potential $1-billion IPO, aiming for a $10 billion valuation.

The trial measures will accelerate listings and represent the biggest changes to the process for almost a decade.

Chairman Joe Longo cannot fix the fact private markets will pay more for smaller businesses than public markets, but he can ...

The chronic condition management company’s debut comes weeks after another digital health company, Hinge Health, went public.

Last Wednesday, the USDC stablecoin issuer priced its upsized initial public offering (IPO) at $31 per share, above its ...

Caris Life Sciences outlined plans for an initial public offering that could give the precision-medicine company a market capitalization topping $5 billion. Caris on Monday said it plans to sell more ...

Omada Health, Inc. (NASDAQ:OMDA) closed its first day of trading at $23 per share on Friday, a 21% jump from the IPO price of $19 per share. On Thursday, Omada Health priced its initial public ...

The fintech major was valued at $6.4 billion in 2022 during its last major fund infusion. The current fund infusion is in the ...

Tether minted $1 billion USDT on Tron, lifting its supply to $76 billion and sparking questions over timing, transparency, ...

Toro draws two bullish ratings and a pair of neutral views as analysts initiated overage of online brokerage firm after its ...

ASIC says it has agreed on new changes that should cut a week from the IPO approval process for companies looking to float on the ASX.